Abbot Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-337
| Closed | -$232K | – | 114 |
|
|
2022
Q3 | $232K | Sell |
337
-30
| -8% | -$20.7K | 0.17% | 102 |
|
|
2022
Q2 | $217K | Hold |
367
| – | – | 0.13% | 116 |
|
|
2022
Q1 | $256K | Hold |
367
| – | – | 0.13% | 116 |
|
|
2021
Q4 | $232K | Sell |
367
-394
| -52% | -$249K | 0.1% | 124 |
|
|
2021
Q3 | $461K | Hold |
761
| – | – | 0.21% | 90 |
|
|
2021
Q2 | $425K | Buy |
761
+50
| +7% | +$27.9K | 0.19% | 94 |
|
|
2021
Q1 | $336K | Buy |
711
+145
| +26% | +$68.5K | 0.15% | 97 |
|
|
2020
Q4 | $273K | Buy |
+566
| New | +$273K | 0.16% | 102 |
|